Active funding phase Lifeline Ventures is an active early-stage VC with recent multi-million growth rounds in 2026 across multiple portfolio companies, signaling ongoing appetite for follow-on investments and strategic funding partnerships.

Tech-forward portfolio Portfolio includes a mix of tech-enabled platforms and hardware (Aiven, Wolt, OURA, Hyperion Robotics, NewOrbit Space, Verda Innovations), suggesting readiness for collaboration with startups leveraging data, AI, space tech, and industrial automation.

Strategic co-investors Recent rounds involve co-leading funds and strategic backers (EIC Fund, HealthCap, Tesi, Sandwater, Voyagers), indicating Lifeline’s strong network and value in syndication and cross-border partnerships.

Fintech and health focus Notable investments in health tech (CurifyLabs, Proteins1) and scalable industrial technology imply opportunities in health tech enablement, bioscience analytics, and life sciences software in Lifeline’s target sectors.

Finnish market leverage Extensive footprint in Finland with a track record involving Finnish unicorns (Wolt, Supercell, OURA, Aiven) positions Lifeline as a gateway for regional startups seeking global scale, talent access, and EU-focused scaling programs.